CAMBRIDGE, Mass., Jan. 9, 2014 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases, today reported preliminary unaudited 2013 net product sales, its outlook for 2014 and other business updates. Marc Beer, Chief Executive Officer, plans to discuss these topics during a live presentation at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco scheduled for Monday, January 13, 2014 at 2:30 p.m. PST (5:30 p.m. EST). The presentation will be webcast live and accessible through the “Investors” section of Aegerion’s website, www.aegerion.com.
Help employers find you! Check out all the jobs and post your resume.
